Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Amortizatization of Intangibles (2016 - 2025)

Tg Therapeutics has reported Amortizatization of Intangibles over the past 10 years, most recently at -$1.7 million for Q4 2025.

  • Quarterly results put Amortizatization of Intangibles at -$1.7 million for Q4 2025, down 432.73% from a year ago — trailing twelve months through Dec 2025 was $1.7 million (down 8.0% YoY), and the annual figure for FY2025 was $1.7 million, down 8.0%.
  • Amortizatization of Intangibles for Q4 2025 was -$1.7 million at Tg Therapeutics, down from $786000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for TGTX hit a ceiling of $3.1 million in Q2 2024 and a floor of -$2.1 million in Q3 2024.
  • Median Amortizatization of Intangibles over the past 5 years was $354000.0 (2023), compared with a mean of $524750.0.
  • Biggest five-year swings in Amortizatization of Intangibles: surged 3177.36% in 2021 and later plummeted 432.73% in 2025.
  • Tg Therapeutics' Amortizatization of Intangibles stood at $1.7 million in 2021, then skyrocketed by 46.4% to $2.5 million in 2022, then tumbled by 70.0% to $763000.0 in 2023, then crashed by 34.73% to $498000.0 in 2024, then plummeted by 432.73% to -$1.7 million in 2025.
  • The last three reported values for Amortizatization of Intangibles were -$1.7 million (Q4 2025), $786000.0 (Q3 2025), and $2.2 million (Q2 2025) per Business Quant data.